PTC Therapeutics: Uncertainty Abounds Ahead Of Q2 Earnings - I'm Upgrading To 'Hold' [Seeking Alpha]
PTC Therapeutics, Inc. (PTCT)
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ptcbio.com
Company Research
Source: Seeking Alpha
The Novartis partnership brings $1B upfront, future milestones, and profit-sharing, significantly strengthening PTC's cash position and long-term prospects. Despite narrowing losses and new product launches, current valuation already prices in optimistic approval scenarios, making risk/reward less compelling. Given the binary catalysts and cash-rich balance sheet, I upgrade my rating from Sell to Hold, awaiting greater clarity after key regulatory events. Alfonso Soler/iStock via Getty Images Investment Overview I have covered PTC Therapeutics ( NASDAQ: PTCT ), the Warren, New Jersey-based, commercial-stage rare disease biotech, three times for Seeking Alpha-in June 2022 May 2023 , and November 2024 , each time issuing a "Sell" recommendation. In If you are interested in keeping up to date with stocks making moves within the biotech, pharma, and healthcare industries and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe
Show less
Read more
Impact Snapshot
Event Time:
PTCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTCT alerts
High impacting PTC Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
PTCT
News
- Japan Sephience Approval Could Be A Game Changer For PTC Therapeutics' (PTCT) Rare-Disease Strategy [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics (PTCT): Valuation Check After First Japan Approval Completes Global Sephience Launch [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan [Yahoo! Finance]Yahoo! Finance
- PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in JapanPR Newswire
- ?????(TM)(???????)??????????(PKU)??????????????? [CNET News]CNET News
PTCT
Earnings
- 11/4/25 - Beat
PTCT
Sec Filings
- 12/23/25 - Form 4
- 12/19/25 - Form 4
- 12/19/25 - Form 144
- PTCT's page on the SEC website